androgenic alopecia. Androgenic alopecia Incl.: male-pattern baldness
Conditions
Interventions
use platelet rich plasma in treatment of androgenetic alopecia in male patients.
Treatment - Other
use platelet rich plasma in treatment of androgenetic alopecia in male patients
Sponsors
Mehrashkar company
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Androgenetic alopecia based on a clinical diagnosis made by a dermatologist;male subjects; 18-50 years old; hair loss longer than 6 months; Hamilton-Norwood grade III-VI;Willingness to participate in the study and giving written informed consent. Exclusion criteria: Any topical or systemic treatment for hair loss in the past 6 months;Scalp infection Malignant disease;Receiving chemotherapy or any immunosuppressive medication Auto-immune disease (Hashimoto, rheumatoid arthritis, lupus, ….);Use of any growth factor containing medication;Hemoglobin level below 10, thrombocytopenia (or platelet count below 100,000);Serum albumin below 2.5 g/dl;History of vascular surgery in the past three months;Addiction to oral or intravenous narcotics; Any systemic disease interacting with hair growth ;History of hematologic disorders; Patient currently enrolled or previously enrolled (within last 3 months) in another clinical trial
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase hair density. Timepoint: after 10 weeks. Method of measurement: trichography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase hair thickness. Timepoint: after 10 weeks. Method of measurement: trichography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaman Ahmad Nasrollahi
Center for Research and Training in Skin diseases and Leprosy
Outcome results
None listed